Full metadata record

DC Field Value Language
dc.contributor.authorHong, Seyoung-
dc.contributor.authorChoi, Dong Wook-
dc.contributor.authorKim, Hong Nam-
dc.contributor.authorPark, Chun Gwon-
dc.contributor.authorLee, Wonhwa-
dc.contributor.authorPark, Hee Ho-
dc.date.accessioned2024-01-19T17:04:11Z-
dc.date.available2024-01-19T17:04:11Z-
dc.date.created2021-09-05-
dc.date.issued2020-07-
dc.identifier.issn1999-4923-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/118441-
dc.description.abstractNanoparticles have been extensively used as carriers for the delivery of chemicals and biomolecular drugs, such as anticancer drugs and therapeutic proteins. Natural biomolecules, such as proteins, are an attractive alternative to synthetic polymers commonly used in nanoparticle formulation because of their safety. In general, protein nanoparticles offer many advantages, such as biocompatibility and biodegradability. Moreover, the preparation of protein nanoparticles and the corresponding encapsulation process involved mild conditions without the use of toxic chemicals or organic solvents. Protein nanoparticles can be generated using proteins, such as fibroins, albumin, gelatin, gliadine, legumin, 30Kc19, lipoprotein, and ferritin proteins, and are prepared through emulsion, electrospray, and desolvation methods. This review introduces the proteins used and methods used in generating protein nanoparticles and compares the corresponding advantages and disadvantages of each.-
dc.languageEnglish-
dc.publisherMDPI-
dc.subjectSILK FIBROIN NANOPARTICLES-
dc.subjectHUMAN SERUM-ALBUMIN-
dc.subjectHIGH-DENSITY-LIPOPROTEIN-
dc.subjectCONTROLLED-RELEASE-
dc.subjectGLIADIN NANOPARTICLES-
dc.subjectPHYSICOCHEMICAL PROPERTIES-
dc.subjectTARGETED DELIVERY-
dc.subjectHSA-NANOPARTICLES-
dc.subjectGENE DELIVERY-
dc.subjectCANCER-CELLS-
dc.titleProtein-Based Nanoparticles as Drug Delivery Systems-
dc.typeArticle-
dc.identifier.doi10.3390/pharmaceutics12070604-
dc.description.journalClass1-
dc.identifier.bibliographicCitationPHARMACEUTICS, v.12, no.7-
dc.citation.titlePHARMACEUTICS-
dc.citation.volume12-
dc.citation.number7-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000557152600001-
dc.identifier.scopusid2-s2.0-85087164173-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeReview-
dc.subject.keywordPlusSILK FIBROIN NANOPARTICLES-
dc.subject.keywordPlusHUMAN SERUM-ALBUMIN-
dc.subject.keywordPlusHIGH-DENSITY-LIPOPROTEIN-
dc.subject.keywordPlusCONTROLLED-RELEASE-
dc.subject.keywordPlusGLIADIN NANOPARTICLES-
dc.subject.keywordPlusPHYSICOCHEMICAL PROPERTIES-
dc.subject.keywordPlusTARGETED DELIVERY-
dc.subject.keywordPlusHSA-NANOPARTICLES-
dc.subject.keywordPlusGENE DELIVERY-
dc.subject.keywordPlusCANCER-CELLS-
dc.subject.keywordAuthorprotein nanoparticle-
dc.subject.keywordAuthordrug delivery-
dc.subject.keywordAuthorbiocompatible-
dc.subject.keywordAuthorbiodegradable-
dc.subject.keywordAuthorcontrolled release-
Appears in Collections:
KIST Article > 2020
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE